An in vivo mouse model in which TGF-β1 was transgenically induced revealed that TGF-β1 induced epithelia hyperproliferation, severe inflammation, and angiogenesis at similar levels to those observed in HNSCCs, suggesting that TGF-β1 provides a tumor-promoting microenvironment [17]. This evidence concerns the gene TGFB1 and neoplasm.